Product Code: 1324
The clinical nutrition market is set to register significant growth through 2030 primarily due to the growing elderly population worldwide. Besides, there is rising awareness regarding health management among the general populace, which is also expected to positively impact the market.
Recently, major players in the industry have been investing in product innovation to improve their business standing, thereby enhancing clinical nutrition market dynamics. For instance, in July 2022, FemTec Health, a health sciences expert, acquired Nutrimedy, the nutrition platform that offers recommendations about nutrition. FemTec planned to integrate the tool into its direct-to-consumer platform, known as Awesome Woman, which not only allows sending products like supplements to customers' homes and at-home tests but also provides telehealth visits.
The clinical nutrition market has been divided in terms of consumer, distribution channel, product, application, and region.
On the basis of distribution channel, the market has been divided into retail stores, pharmacies and drug stores, online channels, and others. Among these, the pharmacies & drug stores segment accounted for about 27.0% revenue share in 2021 and is anticipated to grow sizably through 2030 owing to the easy access and validation of products through licensed pharmacists.
With respect to product, the clinical nutrition market has been divided into infant nutrition, parenteral nutrition, and enteral nutrition. The parenteral nutrition segment is estimated to grow significantly through the analysis timeline on account of the increasing use of parenteral nourishment to cater to the needs of the aging population.
Based on application, the market has been divided into metabolic disorders, gastrointestinal disorders, cancer, neurological diseases, and others. The metabolic disorders segment was valued at over $15,445 million in 2021 and is anticipated to observe robust growth from 2022 to 2030 as a result of mounting prevalence of metabolic diseases. Increasing as well as easy accessibility to products that promote the treatment of metabolic ailments are slated to further facilitate segmental expansion. On the other hand, patients suffering from neurological disorders are at a high risk of dehydration and micronutrient deficiency, which is foreseen to drive the growth of the neurological diseases segment through the review time period.
In the regional context, the clinical nutrition market in Europe is expected to grow significantly up to 2030 backed by soaring number of pediatric patients and a notable surge in chronic diseases. In addition, the market in the Latin America region is set to register significant growth over the forecast period. As per a July 2021 survey, about 39.6% of hospitalized patients in the region were at risk of malnutrition. The growing prevalence of conditions like these is projected to fuel the growth of the LATAM clinical nutrition market in the future.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definitions
- 1.2 Base estimates and working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Clinical nutrition industry 360 degree synopsis, 2017 - 2030 (USD million)
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Consumer trends
- 2.1.4 Application trends
- 2.1.5 Distribution channel trends
- 2.1.6 Regional trends
Chapter 3 Clinical Nutrition Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030 (USD Million)
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing metabolic disorders and other chronic diseases
- 3.3.1.2 High junk food consumption leading to malnourishment
- 3.3.1.3 Rising geriatric population worldwide
- 3.3.1.4 Increasing incidence of pre-mature birth & birth rate
- 3.3.1.5 Increasing adoption of home healthcare
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Stringent government regulations
- 3.3.2.2 Lack of awareness
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By consumer
- 3.4.3 By application
- 3.4.4 By distribution channel
- 3.5 COVID- 19 impact analysis
- 3.6 Regulatory landscape
- 3.7 Porter's Analysis
- 3.8 Competitive landscape, 2021
- 3.8.1 Company matrix analysis, 2021
- 3.9 PESTLE Analysis
Chapter 4 Clinical Nutrition Market, By Product
- 4.1 Key segment trends
- 4.2 Infant nutrition
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.2 Milk based
- 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.3 Soy based
- 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.4 Organic formulas
- 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.5 Others
- 4.2.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Enteral nutrition
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.2 Standard composition
- 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.3 Disease specific composition
- 4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4 Parenteral nutrition
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4.2 Amino acids
- 4.4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4.3 Fats
- 4.4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4.4 Carbohydrates
- 4.4.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4.5 Others
- 4.4.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Clinical Nutrition Market, By Consumer
- 5.1 Key segment trends
- 5.2 Pediatric
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Adult
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Clinical Nutrition Market, By Application
- 6.1 Key segment trends
- 6.2 Cancer
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Metabolic disorders
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Neurological diseases
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.5 Gastrointestinal disorders
- 6.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.6 Others
- 6.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Clinical Nutrition Market, By Distribution Channel
- 7.1 Key segment trends
- 7.2 Retail stores
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.3 Pharmacies & drug stores
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.4 Online channels
- 7.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.5 Others
- 7.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Clinical Nutrition Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.2.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.2.2.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.2.2.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
- 8.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.6.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.2.6.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.2.6.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.2.6.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.2.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.2.7 Canada
- 8.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.7.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.2.7.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.2.7.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.2.7.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.2.7.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.2.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.3.2.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.3.2.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.3.6 Germany
- 8.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.6.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.3.6.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.3.6.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.3.6.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.3.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.3.7 France
- 8.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.7.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.3.7.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.3.7.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.3.7.2 Market size, by formulation, 2017 - 2030 (USD Million)
- 8.3.7.3 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.3.7.4 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.7.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.3.8 UK
- 8.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.8.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.3.8.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.3.8.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.3.8.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.3.8.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.3.9 Spain
- 8.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.9.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.3.9.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.3.9.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.3.9.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.3.9.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.9.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.3.10 Italy
- 8.3.10.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.10.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.3.10.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.3.10.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.3.10.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.3.10.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.10.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.2.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.4.2.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.4.2.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.6 China
- 8.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.6.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.4.6.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.4.6.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.4.6.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.4.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.7 Japan
- 8.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.7.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.4.7.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.4.7.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.4.7.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.4.7.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.8 India
- 8.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.8.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.4.8.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.4.8.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.4.8.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.4.8.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.9 Australia
- 8.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.9.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.4.9.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.4.9.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.4.9.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.4.9.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.9.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.10 South Korea
- 8.4.10.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.10.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.4.10.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.4.10.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.4.10.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.4.10.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.10.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.2.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.5.2.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.5.2.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
- 8.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.6.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.5.6.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.5.6.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.5.6.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.5.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
- 8.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.7.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.5.7.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.5.7.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.5.7.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.5.7.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.5.8 Argentina
- 8.5.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.8.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.5.8.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.5.8.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.5.8.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.5.8.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.6 MEA
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.2.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.6.2.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.6.2.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.6.6 South Africa
- 8.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.6.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.6.6.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.6.6.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.6.6.2 Market size, by formulation, 2017 - 2030 (USD Million)
- 8.6.6.3 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.6.6.4 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.6.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
- 8.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.7.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.6.7.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.6.7.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.6.7.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.6.7.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
- 8.6.8 UAE
- 8.6.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.8.1.1 Market size, by infant nutrition, 2017 - 2030 (USD Million)
- 8.6.8.1.2 Market size, by enteral nutrition, 2017 - 2030 (USD Million)
- 8.6.8.1.3 Market size, by parenteral nutrition, 2017 - 2030 (USD Million)
- 8.6.8.2 Market size, by consumer, 2017 - 2030 (USD Million)
- 8.6.8.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
- 9.1 Competitive dashboard, 2021
- 9.2 Abbott Laboratories (Abbott Nutrition)
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
- 9.3 B Braun Melsungen AG
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
- 9.4 Baxter International Inc.
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
- 9.5 Fresenius Kabi
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
- 9.6 Mead Johnson (Reckitt Benckiser)
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
- 9.7 Nestle Health Science
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
- 9.8 Perrigo
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
- 9.9 Pfizer, Inc.
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
- 9.10 Danone
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
- 9.11 Hero Nutritionals Inc.
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
- 9.12 AYMES International Ltd
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
- 9.13 Medifood International Ltd
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis
- 9.14 Royal DSM
- 9.14.1 Business overview
- 9.14.2 Financial data
- 9.14.3 Product landscape
- 9.14.4 Strategic outlook
- 9.14.5 SWOT analysis
- 9.15 BASF SE
- 9.15.1 Business overview
- 9.15.2 Financial data
- 9.15.3 Product landscape
- 9.15.4 Strategic outlook
- 9.15.5 SWOT analysis
- 9.16 Aculife Healthcare Pvt Ltd
- 9.16.1 Business overview
- 9.16.2 Financial data
- 9.16.3 Product landscape
- 9.16.4 Strategic outlook
- 9.16.5 SWOT analysis
- 9.17 Amanta Healthcare
- 9.17.1 Business overview
- 9.17.2 Financial data
- 9.17.3 Product landscape
- 9.17.4 Strategic outlook
- 9.17.5 SWOT analysis
- 9.18 Hormel Foods Corporation
- 9.18.1 Business overview
- 9.18.2 Financial data
- 9.18.3 Product landscape
- 9.18.4 Strategic outlook
- 9.18.5 SWOT analysis
- 9.19 Meiji Holdings Co Ltd
- 9.19.1 Business overview
- 9.19.2 Financial data
- 9.19.3 Product landscape
- 9.19.4 Strategic outlook
- 9.19.5 SWOT analysis
- 9.20 Grifols SA
- 9.20.1 Business overview
- 9.20.2 Financial data
- 9.20.3 Product landscape
- 9.20.4 Strategic outlook
- 9.20.5 SWOT analysis